GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XSWX:MRK) » Definitions » Ending Cash Position

Merck (XSWX:MRK) Ending Cash Position : CHF5,975 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Merck Ending Cash Position?

Merck's Ending Cash Position for the quarter that ended in Dec. 2023 was CHF5,975 Mil.

Merck's quarterly Ending Cash Position increased from Jun. 2023 (CHF5,143 Mil) to Sep. 2023 (CHF7,799 Mil) but then declined from Sep. 2023 (CHF7,799 Mil) to Dec. 2023 (CHF5,975 Mil).

Merck's annual Ending Cash Position increased from Dec. 2021 (CHF7,522 Mil) to Dec. 2022 (CHF11,899 Mil) but then declined from Dec. 2022 (CHF11,899 Mil) to Dec. 2023 (CHF5,975 Mil).


Merck Ending Cash Position Historical Data

The historical data trend for Merck's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Ending Cash Position Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,761.15 7,243.13 7,521.81 11,899.33 5,974.90

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,056.94 5,143.09 7,798.63 5,974.90 -

Merck Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Merck's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=11046.09+-5071.187
=5,975

Merck's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=7496.951+-1522.048
=5,975


Merck Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Merck's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (XSWX:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (XSWX:MRK) Headlines

From GuruFocus

Merck & Co Inc To Host ESMO Call (Virtual) Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Investor Event at ACC.23/WCC Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Investor Event at ASCO 2023 Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024